In Med Pharmaceuticals Inc. filed an 8-K with the SEC
Primary filing notice from SEC EDGAR. Filed: 2026-07-22 AccNo: 0001213900-26-080414 Size: 303 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Primary filing notice from SEC EDGAR. Filed: 2026-07-22 AccNo: 0001213900-26-080414 Size: 303 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits